Population pharmacokinetics of cefepime in the neonate

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 7, 2005, Pages 2760-2766

  Capparelli, Edmund ^a   Hochwald, Christine ^d   Rasmussen, Maynard ^b,c   Parham, Amy ^d   Bradley, John ^b,c   Moya, Fernando ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c SHARP HEALTHCARE   (United States)

^d Memorial Hermann Children's Hospital   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CREATININE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; POPULATION MODEL; PREMATURITY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TOTAL BODY WATER;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CREATININE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS, NEONATAL; MALE; SOFTWARE;

EID: 21444433347     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.7.2760-2766.2005     Document Type: Article

References (26)

1. Adams-Chapman, I., and B. J. Stell. 2002. Prevention of nosocomial infections in the neonatal intensive care unit. Curr. Opin. Pediatr. 14:157-164.
2. Andes, D., J. Anon, M. R. Jacobs, and W. A. Craig. 2004. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Clin. Lab. Med. 24:477-502.
3. Aperia, A., O. Broberger, U. Broberger, P. Herin, and R. Zetterstrom. 1981. Postnatal development of renal function in pre-term and full-term infants. Acta Paediatr. Scand. 70:183-187.
4. Arant, B. S., Jr. 1978. Developmental patterns of renal functional maturation compared in the human neonate. J. Pediatr. 92:705-712.
5. Beal, S. L., and L. B. Sheiner. 1998. NONMEM users' guide. Parts I to VII. University of California, San Francisco, Calif.
6. Birnbaumer, D., and M. Fernandez-Frackelton. 2000. The new antibiotics. Emerg. Med. Clin. N. Am. 18:671-708.
7. Bristol-Myers Squibb Company. 2003. Maxipime prescribing information. Bristol-Myers Squibb Company, Princeton, N.J.
8. Burgess, D. S., R. W. Hastings, and T. C. Hardin. 2000. Pharmacokinetics and pharmacodynamics of cefepime administered by intermittent and continuous infusion. Clin. Ther. 22:66-75.
9. Bush, K. 2001. New beta-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin. Infect. Dis. 32:1085-1089.
10. Capparelli, E. V., J. R. Lane, G. L. Romanowski, E. J. McFeely, W. Murray, P. Sousa, C. Kildoo, and J. D. Connor. 2001. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J. Clin. Pharmacol. 41:927-934.
11. Edwards, W. H. 2002. Preventing nosocomial bloodstream infection in very low birth weight infants. Semin. Neonatol. 7:325-333.
12. Foca, M. D. 2002. Pseudomonas aeruginosa infections in the neonatal care unit. Semin. Perinatol. 26:332-339.
13. Gupta, A. 2002. Hospital-acquired infections in the neonatal intensive care unit-Klebsiella pneumoniae. Semin. Perinatol. 26:340-345.
14. Hack, M., and A. A. Fanaroff. 2000. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Semin. Neonatal. 5:89-106.
15. Kalman, D., S. L. Barriere, and B. L. Johnson, Jr. 1992. Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid. Antimicrob. Agents Chemother. 36:453-457.
16. Kim, Y.-K., H. Pai, H.-J. Lee, S.-E. Park, E.-H. Choi, J. Kim, J.-H. Kim, and E.-C. Kim. 2002. Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob. Agents Chemother. 46:1481-1491.
17. Liu, S. C., H. S. Leu, M. Y. Yen, P. I. Lee, and M. C. Chou. 2002. Study of an outbreak of Enterobacter cloacae sepsis in a neonatal intensive care unit: the application of epidemiologic chromosome profiling by pulsed-field gel electrophoresis. Am. J. Infect. Control 30:381-385.
18. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Pessoa-Silva, C. L., B. Meurer Moreira, V. Camara Almeida, B. Flannery, M. C. Almeida Lins, J. L. Mello Sampaio, L. Martins Teixeira, L. E. Vaz Miranda, L. W. Riley, and J. L. Gerberding. 2003. Extended-spectrum β-lactamase- producing Klebsiella pneumoniae in a neonatal intensive care unit: risk factors for infection and colonization. J. Hosp. Infect. 53:198-206.
20. Reed, M. D., T. S. Yamashita, C. K. Knupp, J. M. Veazey, Jr., and J. L. Blumer. 1997. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children. Antimicrob. Agents Chemother. 41:1783-1787.
21. Schelonka, R. L., and A. J. Infante. 1998. Neonatal immunology. Semin. Perinatol. 22:2-14.
22. Sonntag, J., B. Prankel, and S. Waltz. 1996. Serum creatinine concentration, urinary creatinine excretion and creatinine clearance during the first 9 weeks in premature infants with a birth weight below 1500 g. Eur. J. Pediatr. 155:815-819.
23. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, W. Oh, C. R. Bauer, S. B. Korones, S. Shankaran, A. R. Laptook, D. K. Stevenson, L. A. Papile, and W. K. Poole. 2002. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N. Engl. J. Med. 347:280-281.
24. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, W. Oh, C. R. Bauer, S. B. Korones, S. Shankaran, A. R. Laptook, D. K. Stevenson, L. A. Papile, and W. K. Poole. 2002. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291.
25. Stover, B. H., S. T. Shulman, D. F. Bratcher, M. T. Brady, G. L. Levine, W. R. Jarvis, and the Pediatric Prevention Network. 2001. Nosocomial infection rates in U.S. children's hospitals' neonatal and pediatric intensive care units. Am. J. Infect. Control 29:152-157.
26. Tam, V. H., P. S. McKinnon, R. L. Akins, G. L. Drusano, and M. J. Rybak. 2003. Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function. Antimicrob. Agents Chemother. 47:1853-1861.